Ruane Clinical Research Group, Inc ( Site 5658) — Los Angeles, California

Public research footprint of Ruane Clinical Research Group, Inc ( Site 5658), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

HIV-1 Infection · Nonalcoholic Steatohepatitis (NASH) With Fibrosis · Pre-Exposure Prophylaxis of HIV Infection · Hepatitis B, Chronic

Recently updated registry entries

NCT07473778 — Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention (Recruiting)
NCT07266831 — A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been… (Recruiting)
NCT04526665 — Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Ruane Clinical Research Group, Inc ( Site 5658)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.